Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome

Structure
Michael GrollHuib Ovaa

Abstract

The dipeptide boronic acid bortezomib, also termed VELCADE, is a proteasome inhibitor now in use for the treatment of multiple myeloma, and its use for the treatment of other malignancies is being explored. We determined the crystal structure of the yeast 20S proteasome in complex with bortezomib to establish the specificity and binding mode of bortezomib to the proteasome's different catalytically active sites. This structure should enable the rational design of new boronic acid derivatives with improved affinities and specificities for individual active subunits.

References

Oct 6, 1997·The Journal of Biological Chemistry·W HeinemeyerD H Wolf
Oct 3, 1998·Acta Crystallographica. Section D, Biological Crystallography·A T BrüngerG L Warren
Jan 1, 1999·Bioorganic & Medicinal Chemistry Letters·J AdamsR L Stein
Sep 29, 1999·Proceedings of the National Academy of Sciences of the United States of America·M GrollR Huber
Mar 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·T Nazif, M Bogyo
May 22, 2001·Cellular and Molecular Life Sciences : CMLS·B Walker, J F Lynas
Aug 22, 2001·Chemistry & Biology·A F Kisselev, A L Goldberg
Jan 5, 2002·Chemistry & Biology·J L HarrisB J Backes
May 8, 2002·Biochemistry·Robert E London, Scott A Gabel
May 17, 2002·Structure·Masaki UnnoTomitake Tsukihara
Apr 26, 2003·Acta Crystallographica. Section A, Foundations of Crystallography·Zbyszek OtwinowskiWladek Minor
Mar 10, 2004·Biochemistry·Thomas R TransueRobert E London
Jan 1, 1993·Acta Crystallographica. Section D, Biological Crystallography·A T Brünger
Dec 2, 2004·Biochimica Et Biophysica Acta·Michael Groll, Robert Huber
Jan 29, 2005·Chembiochem : a European Journal of Chemical Biology·Michael GrollRobert Huber
May 27, 2005·Journal of Medicinal Chemistry·Venkat R MacherlaBarbara C M Potts
May 28, 2005·The Journal of Biological Chemistry·Hannes A BraunBoris Schmidt
Jun 17, 2005·The New England Journal of Medicine·Paul G RichardsonUNKNOWN Assessment of Proteasome Inhibition for Extending Remissions (APEX) Investigators

❮ Previous
Next ❯

Citations

Jan 3, 2014·The Journal of Clinical Investigation·Nathaniel M Weathington, Rama K Mallampalli
Feb 25, 2014·European Journal of Medicinal Chemistry·Kety ScarbaciMaria Zappalà
Mar 1, 2014·Nature Reviews. Drug Discovery·Matthias Dobbelstein, Ute Moll
Feb 21, 2014·Biochemical Pharmacology·Denise NiewerthJacqueline Cloos
Apr 15, 2014·Cancer Chemotherapy and Pharmacology·Sudipa S RoyJoseph K Agyin
Jan 9, 2014·EMBO Molecular Medicine·Michael BaslerChristopher J Kirk
Jun 27, 2014·Organic & Biomolecular Chemistry·Bo-Tao XinHerman S Overkleeft
Jun 20, 2014·European Journal of Medicinal Chemistry·Valeria TroianoMaria Zappalà
Jan 21, 2014·Antioxidants & Redox Signaling·Guillem Paniagua SorianoBogdan I Florea
Dec 5, 2009·Advances in Hematology·Adele BologneseBruno Rotoli
Feb 14, 2012·Nature Chemical Biology·Sarah A WackerTarun M Kapoor
Sep 4, 2008·Journal of the American Chemical Society·Minyong LiBinghe Wang
Oct 22, 2008·Journal of the American Chemical Society·Michael GrollEric N Jacobsen
Oct 9, 2009·The Journal of Biological Chemistry·Ami Navon, Aaron Ciechanover
Oct 14, 2009·Breast Cancer Research : BCR·Joseph K AgyinRajeshwar R Tekmal
Dec 9, 2009·Journal of the American Chemical Society·Heidi J ImkerWilliam M Wuest
Apr 3, 2010·Proceedings of the National Academy of Sciences of the United States of America·Harald M H G AlbersHuib Ovaa
Aug 5, 2011·Organic Letters·William M WuestChristopher T Walsh
Sep 3, 2011·ACS Chemical Biology·Andrew J KaleBradley S Moore
Jan 5, 2012·PloS One·Erika SuzukiChristopher J Kirk
Jun 16, 2012·Journal of the American Chemical Society·Donghui WeiChang-Guo Zhan
Oct 16, 2009·Organic & Biomolecular Chemistry·Hyun Seung BanHiroyuki Nakamura
Sep 10, 2011·Natural Product Reports·Daniel KrahnMarkus Kaiser
Feb 2, 2011·Expert Opinion on Therapeutic Targets·Serena TschanJürgen F J Kun
Aug 24, 2013·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Chih-Cheng ChaiPo-Shen Pan
Jan 16, 2016·Journal of Medicinal Chemistry·Sabin Llona-MinguezThomas Helleday
Jun 1, 2014·Expert Opinion on Drug Discovery·Chiara PautassoAntonio Palumbo
Oct 27, 2011·Biochemical Pharmacology·Leonie H A M de WiltFrank A E Kruyt
Jan 8, 2016·Annual Review of Pharmacology and Toxicology·Paweł Śledź, Wolfgang Baumeister
Jul 20, 2010·Bioorganic Chemistry·Tomasz RumanWojciech Rode
Jan 20, 2010·Bioorganic & Medicinal Chemistry Letters·Kazuki ShimizuHiroyuki Nakamura
Oct 27, 2009·Bioorganic Chemistry·Tomasz RumanWojciech Rode
Sep 15, 2009·Bioorganic & Medicinal Chemistry·Yongqiang ZhuRuntao Li
May 12, 2009·Bioorganic & Medicinal Chemistry Letters·Hiroyuki NakamuraAkira Asai

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.